Am Pharma

Equipoise, a trade name for the anabolic-androgenic steroid boldenone undecylenate, is manufactured and distributed by companies like Galaxo Pharma. Initially developed for veterinary use, especially in horses, it has also found applications in bodybuilding and athletics. Properties and uses

• Equipoise has strong anabolic and moderate androgenic properties.
• It's known for promoting lean muscle mass, enhancing endurance, and increasing appetite.
• It has a low rate of aromatization, meaning it does not convert to estrogen easily, potentially reducing water retention and the risk of gynecomastia compared to some other steroids. 

Side effects and risks

• Potential side effects include acne, oily skin, hair loss (in susceptible individuals), increased body hair growth, and suppression of natural testosterone production.
• It can negatively impact cholesterol levels, lowering HDL ("good" cholesterol) and raising LDL ("bad" cholesterol), increasing the risk of cardiovascular disease.
• In women, it may lead to virilization, causing effects like voice deepening and clitoral enlargement. 

Legal status

• The legal status of Equipoise for human use varies by jurisdiction. In the United States, it is a controlled substance and its use in humans is generally illicit.
• However, it remains available for veterinary use in some countries like Australia and the United States. 

Galaxo Pharma

• Galaxo Pharma manufactures and distributes Equipoise in injectable liquid form, with compositions such as boldenone undecylenate.
• They cater to both domestic and international markets